NCT02520297View on ClinicalTrials.gov

A Pilot Study of TRV130 for the Treatment of Fracture Pain

PHASE2TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

October 20, 2015

Primary Completion Date

October 23, 2015

Study Completion Date

October 23, 2015

Conditions

Pain

Interventions

DRUG

TRV130

Drug

Trial Locations (1)

Unknown

Trevena, Inc., Indianapolis

Sponsors

Collaborators (1)

Kestrel Biologic

All Listed Sponsors

collaborator

Kestrel Biologic

INDUSTRY

lead

Trevena Inc.

INDUSTRY

NCT02520297 - A Pilot Study of TRV130 for the Treatment of Fracture Pain | Biotech Hunter | Biotech Hunter